These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4927757)

  • 41. The potential of lymphocytes from patients with leukaemia and reticuloses to transform under the influence of Phytohaemagglutinin.
    Elves MW; Collinge M; Israëls MC
    Acta Haematol; 1967; 37(2):100-8. PubMed ID: 4961914
    [No Abstract]   [Full Text] [Related]  

  • 42. [Stimulation of peripheral human lymphocytes in vitro with Zn 2+ in patients with lymphogranulomatosis and chronic lymphatic leukemia].
    Rühl H; Scholle H; Krichner H
    Acta Haematol; 1971; 46(6):326-37. PubMed ID: 5004482
    [No Abstract]   [Full Text] [Related]  

  • 43. [Azurophilic granulation in lymphocytes. 3. Behavior of lymphocytes with azurophilic granulation in various hematologic diseases].
    Sahi J; Stobbe H; Klatt R; Heine KM; Hofer E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):385-8. PubMed ID: 4107573
    [No Abstract]   [Full Text] [Related]  

  • 44. Further studies on the plasma lymphocytosis stimulating factor in chronic lymphatic leukaemia and some other disease states.
    METCALF D
    Br J Cancer; 1956 Sep; 10(3):431-41. PubMed ID: 13396092
    [No Abstract]   [Full Text] [Related]  

  • 45. Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia.
    Holm G; Perlmann P; Johansson B
    Clin Exp Immunol; 1967 May; 2(3):351-60. PubMed ID: 6035198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymphocyte transformation by phytohemagglutinin. 3. In vitro cytotoxicity.
    Thomas JW; Boldt W; Horrocks G
    Can Med Assoc J; 1968 Aug; 99(7):303-7. PubMed ID: 5676083
    [No Abstract]   [Full Text] [Related]  

  • 47. [Morphofunctional characteristics of blasts in lymphoblastic leukemia and lymphoblastic lymphosarcoma].
    Frenkel' MA; Tupitsyn NN; Solov'eva EA
    Ter Arkh; 1987; 59(6):31-4. PubMed ID: 3477031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The blood lymphocytes under the light- and electron microscope after stimulation with phytohemagglutinin. II. Phytohemagglutinin transformation of lymphocytes by Hodgkin's disease and chronic lymphatic leukemia].
    Pappas A; Orfanos C; Scheurlen PG
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 149(4):294-305. PubMed ID: 5772875
    [No Abstract]   [Full Text] [Related]  

  • 49. [Blastic transformation of lymphocytes in culture stimulated by phytohemagglutinin (PHA) in hypoplastic anemia and lymphoproliferative diseases].
    Samoĭlina NL; Polianskaia AM
    Probl Gematol Pereliv Krovi; 1969 Oct; 14(10):3-13. PubMed ID: 4983365
    [No Abstract]   [Full Text] [Related]  

  • 50. The thymic origin of the plasma lymphocytosis stimulating factor.
    METCALF D
    Br J Cancer; 1956 Sep; 10(3):442-57. PubMed ID: 13396093
    [No Abstract]   [Full Text] [Related]  

  • 51. Asparagine metabolism in some lymphoproliferative disorders.
    Dimitrov NV; Brodsky I
    Cancer Res; 1970 May; 30(5):1338-43. PubMed ID: 5269358
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 53. [Structure and function of erythrocytes in lymphomas].
    Loseva MI; Shpagina LA; Lisukov IA; Ziubina LIu; Kovynev IB
    Gematol Transfuziol; 1992; 37(5-6):16-20. PubMed ID: 1478424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chromatin and other cytologic indices in chronic lymphocytic leukemia.
    Schrek R; Knospe WH; Trobaugh FE
    J Lab Clin Med; 1970 Feb; 75(2):217-24. PubMed ID: 5467082
    [No Abstract]   [Full Text] [Related]  

  • 55. Circulation and emigration kinetics of blood lymphocytes in lymphoma patients.
    Bremer K; Engeset A; Fröland SS
    Lymphology; 1978 Dec; 11(4):231-7. PubMed ID: 310921
    [No Abstract]   [Full Text] [Related]  

  • 56. Lymphocyte populations in chronic lymphocytic leukemia.
    Flad HD; Huber C; Bremer K; Huber H
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:297. PubMed ID: 4408300
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum migration-inhibitory activity in patients with lymphoproliferative diseases.
    Cohen S; Fisher B; Yoshida T; Bettigole RE
    N Engl J Med; 1974 Apr; 290(16):882-6. PubMed ID: 4593612
    [No Abstract]   [Full Text] [Related]  

  • 58. Impaired recirculation of B lymphocytes in chronic lymphocytic leukemia.
    Flad GD; Huber C; Bremer K; Menne HD; Huber H
    Eur J Immunol; 1973 Nov; 3(11):688-93. PubMed ID: 4129486
    [No Abstract]   [Full Text] [Related]  

  • 59. [Differences in lymphocyte properties in Hodgkin's disease and chronic lympholeukosis].
    Veskova TK; Duk IL; Svet-Moldavskiĭ GIa
    Biull Eksp Biol Med; 1971 Jan; 71(1):49-51. PubMed ID: 5549004
    [No Abstract]   [Full Text] [Related]  

  • 60. Persistent abnormalities in red cell parameters following treatment of lymphoma.
    Meytes D; Leshno D; Berkowicz M; Modan M; Ramot B
    Leuk Lymphoma; 1994 Oct; 15(3-4):341-5. PubMed ID: 7866284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.